A new drug currently being developed to treat diabetes and obesity could become the world’s first $100 billion drug
Investors Take Note: The drug, received Food and Drug Administration approval as a treatment for Type 2 diabetes earlier this year. It has also shown in clinical trials that it can help people lose up to 20% of their body weight. The experimental obesity drug now has a Fast Track designation from the FDA, and the company plans to begin a rolling submission as it seeks approval for a weight-loss indication
The stock price of the Company has soared 257% over the last three years and our Algorithm sees further upside of at least 30% in 2023 alone
Make Money From The World’s First $100 Billion Drug
Passive Income: Earn a passive income from a suite of funds by a European Fund Manager that each pay between 70-90% in 12 months and 10-13% every 4 weeks
Active Income: Make at least 30% per year From The World’s First $100 Billion Drug
Interested? Please Send Us Your Email Address At bit.ly/AlgoTrader Or Contact Us To Indicate Your Interest For Details
Join Our Passive Wealth WhatsApp Group Now: bit.ly/3AQXlRt
PassiveIncome #ActiveIncome #MoneyMakesMoney #MoneyNeverSleeps
AlgoTrader 